Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Tipo de estudo
Intervalo de ano de publicação
1.
J Infect Dis ; 191(3): 367-71, 2005 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-15633095

RESUMO

Inguinal lymph nodes from 24 human immunodeficiency virus (HIV) type 1-infected subjects without Kaposi sarcoma-associated herpesvirus (KSHV)-associated diseases were examined for KSHV infection. KSHV-infected cells were detected at a very low frequency in the lymph nodes of 7 subjects (median frequency, 2 infected cells/10(7) lymph node cells). Latent, but not lytic, KSHV gene expression was detected and KSHV-infected cells were located in B cell-rich areas of lymph node follicles. These findings provide evidence that, in the absence of KSHV-associated diseases, latent infection of lymph node cells provides a mechanism for the persistence of KSHV in KSHV/HIV-1-coinfected persons.


Assuntos
Linfócitos B/virologia , Infecções por HIV/complicações , Herpesvirus Humano 8/fisiologia , Linfonodos/citologia , Sarcoma de Kaposi/complicações , Latência Viral , Adulto , Reservatórios de Doenças , Feminino , HIV-1/fisiologia , Humanos , Linfonodos/virologia , Masculino , Pessoa de Meia-Idade , Sarcoma de Kaposi/virologia
2.
Am J Hematol ; 77(4): 410-2, 2004 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-15551282

RESUMO

The effects of hematopoietic stem cell (HSC) mobilization on Kaposi's sarcoma-associated herpesvirus (KSHV) were evaluated in three KSHV and human immunodeficiency virus type 1 co-infected subjects. KSHV DNA was not detected in purified CD34+ cell preparations from the period of filgrastim treatment. However, two of 3 subjects had transiently increased cell-free plasma KSHV DNA during filgrastim treatment. Peak plasma KSHV DNA (2,600 and 4,300 copies/mL) occurred on day 4 and declined to below the limit of detection by day 7. These findings suggest that, although CD34+ cell preparations do not have evidence of KSHV infection, HSC mobilization may stimulate KSHV replication in other cellular compartments that contribute to KSHV viremia.


Assuntos
Fator Estimulador de Colônias de Granulócitos/uso terapêutico , Infecções por HIV/virologia , Mobilização de Células-Tronco Hematopoéticas , Herpesvirus Humano 8/isolamento & purificação , Sarcoma de Kaposi/virologia , Viremia/sangue , DNA Viral/sangue , Filgrastim , Infecções por HIV/sangue , Infecções por HIV/complicações , HIV-1/isolamento & purificação , Herpesvirus Humano 8/fisiologia , Humanos , RNA Viral/sangue , Proteínas Recombinantes , Sarcoma de Kaposi/sangue , Sarcoma de Kaposi/complicações , Replicação Viral/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...